Drug-drug Interaction Between Ciprofol and Mefanamic Acid or Valproate
NCT05181007 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 41
Last updated 2022-07-14
Summary
study the effect of mefanamic acid or valproate on ciprofol
Conditions
- Drug Drug Interaction
Interventions
- DRUG
-
Mefanamic Acid
mefanamic acid once every 6 hours on Day 4 and Day 5, Ciprofol on Day 1 and Day 5
- DRUG
-
valproate once daily on Day 4 to Day 8, Ciprofol on Day 1 and Day 8
Sponsors & Collaborators
-
Haisco Pharmaceutical Group Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SEQUENTIAL
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-12-17
- Primary Completion
- 2022-03-23
- Completion
- 2022-06-01
- FDA Drug
- Yes
Countries
- China
Study Locations
More Related Trials
-
Pharmacogenetics-Based Study on Individualized Use of Sodium Valproate
NCT07046676 ·Status: RECRUITING ·Phase: PHASE4
-
Drug Resistant Epilepsy: Clinical and Genetic Study
NCT04166305 ·Status: UNKNOWN
-
Valproic Acid Use in Patients With Neurological Disorders
NCT05830981 ·Status: COMPLETED ·Phase: NA
-
A Study on the Effects of Valproate on the Pharmacokinetics of RO4917838 in Healthy Volunteers
NCT01495104 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics, Efficacy, and Safety of Perampanel Oral Suspension on Seizure Frequency in Pediatric Subjects Maintained on One to Three Stable Antiepileptic Drugs
NCT01527006 ·Status: COMPLETED ·Phase: PHASE2
-
Open-label Drug Interaction Study Between Eslicarbazepine Acetate and Lamotrigine.
NCT02283801 ·Status: COMPLETED ·Phase: PHASE1
-
A Open-label, Drug Interaction Study Between Eslicarbazepine Acetate and Topiramate
NCT02283814 ·Status: COMPLETED ·Phase: PHASE1
-
Role of Clinical Pharmacists in Epilepsy Management
NCT04967326 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Verapamil in Refractory Epilepsy
NCT01126307 ·Status: UNKNOWN ·Phase: NA
-
The Efficacy and Safety of Minocycline in the Treatment of Drug-resistant Epilepsy in NORSE Patients
NCT05958069 ·Status: UNKNOWN ·Phase: NA
-
Comparison Between Melatonin and Diazepam for Prevention of Recurrent Simple Febrile Seizures
NCT03631901 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Excretion Balance and Pharmacokinetics of [14C]-Sodium Valproate (3.7 MBq) in Healthy Postmenopausal or Permanently Sterile Female Subjects
NCT03681158 ·Status: COMPLETED ·Phase: PHASE1
-
Medication Adherence in Individuals With Epilepsy
NCT01566500 ·Status: COMPLETED
-
Effects of Perampanel on Neurophysiology Test Perimeters
NCT03653741 ·Status: COMPLETED ·Phase: PHASE4
-
Antiepileptic Drugs in Elderly Patients
NCT05459597 ·Status: RECRUITING
-
A Pharmacokinetic Study of a Single-Dose of Diazepam Nasal Spray in Adult Epileptic Patients Experiencing a Seizure Episode
NCT01417078 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Anti-epileptic Drugs on Mitochondrial Activity
NCT01218321 ·Status: COMPLETED
-
Does Memantine Improve Verbal Memory Task Performance in Subjects With Partial Epilepsy and Memory Dysfunction?
NCT01054599 ·Status: COMPLETED ·Phase: NA
-
Diazepam Trial in GAD65 Associated Epilepsy
NCT05361447 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
A Study of Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy
NCT02607891 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Perampanel in the Treatment of Refractory Status Epilepticus
NCT05684978 ·Status: TERMINATED ·Phase: PHASE4
-
CX-8998 for Absence Seizures
NCT03406702 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate Pharmacokinetics and Tolerability of Multiple Doses of Eslicarbazepine Acetate and Oxcarbazepine
NCT00900237 ·Status: COMPLETED ·Phase: PHASE1
-
Open-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset Epilepsy
NCT06453213 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Perampanel for Treatment of Adults With Refractory Focal Epilepsy : a Pilot Study.
NCT02727101 ·Status: TERMINATED ·Phase: PHASE4